Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0002874 (
aplastic anemia
)
5,905
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Telomerase consists of the catalytic protein TERT and the RNA TERC. Mutations in TERC are linked to human diseases, but the underlying mechanisms are poorly understood. Here we report that the RNA-binding protein
HuR
associates with TERC and promotes the assembly of the TERC/TERT complex by facilitating TERC C106 methylation. Dyskeratosis congenita (DC)-related TERC U100A mutation impair the association of
HuR
with TERC, thereby reducing C106 methylation. Two other TERC mutations linked to
aplastic anemia
and autosomal dominant DC, G107U, and GC107/108AG, likewise disrupt methylation at C106. Loss-of-
HuR
binding and hence lower TERC methylation leads to decreased telomerase activity and telomere shortening. Furthermore,
HuR
deficiency or mutation of mTERC
HuR
binding or methylation sites impair the renewal of mouse hematopoietic stem cells, recapitulating the bone marrow failure seen in DC. Collectively, our findings reveal a novel function of
HuR
, linking
HuR
to telomerase function and TERC-associated DC.
...
PMID:HuR regulates telomerase activity through TERC methylation. 2998 36